Literature DB >> 7824175

Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections.

N Iwamoto1, E Nishiyama, J Ohwada, H Arai.   

Abstract

C-reactive protein (CRP) is a well-known serum protein which increases during inflammation and deposits in damaged tissues. To establish whether CRP appears in brain of Alzheimer's disease (AD), we immunohistochemically investigated tissue sections which were pretreated with formic acid. Positive immunostaining by anti-CRP antibodies was clearly recognized in senile plaques (SP) in the pretreated tissue sections, with very weak immunostaining in non-treated sections. These findings may suggest that the formation process of SP includes an acute-phase inflammatory state.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824175     DOI: 10.1016/0304-3940(94)90035-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  39 in total

1.  Memory deficits and neurochemical changes induced by C-reactive protein in rats: implication in Alzheimer's disease.

Authors:  Huan-Bing Lin; Xue-Mei Yang; Tie-Jun Li; Yu-Fang Cheng; Han-Ting Zhang; Jiang-Ping Xu
Journal:  Psychopharmacology (Berl)       Date:  2009-03-05       Impact factor: 4.530

2.  Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old.

Authors:  B Adar Kravitz; Maria M Corrada; Claudia H Kawas
Journal:  Alzheimers Dement       Date:  2009-07       Impact factor: 21.566

Review 3.  Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation.

Authors:  Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease.

Authors:  Sid E O'Bryant; Fan Zhang; Leigh A Johnson; James Hall; Melissa Edwards; Paula Grammas; Esther Oh; Constantine G Lyketsos; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.

Authors:  H Hampel; S E O'Bryant; J I Castrillo; C Ritchie; K Rojkova; K Broich; N Benda; R Nisticò; R A Frank; B Dubois; V Escott-Price; S Lista
Journal:  J Prev Alzheimers Dis       Date:  2016-09-06

6.  Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid.

Authors:  P T Johnson; K E Betts; M J Radeke; G S Hageman; D H Anderson; L V Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-01       Impact factor: 11.205

7.  The link between C-reactive protein and Alzheimer's disease among Mexican Americans.

Authors:  Sid E O'Bryant; Leigh Johnson; Melissa Edwards; Holly Soares; Michael D Devous; Sarah Ross; Geoffrey Rohlfing; James Hall
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?

Authors:  Zaldy S Tan; Sudha Seshadri
Journal:  Alzheimers Res Ther       Date:  2010-04-12       Impact factor: 6.982

9.  Effects of C-reactive protein and pentosan polysulphate on human complement activation.

Authors:  Andis Klegeris; Edith A Singh; Patrick L McGeer
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

10.  Decreased C-reactive protein levels in Alzheimer disease.

Authors:  Sid E O'Bryant; Stephen C Waring; Valerie Hobson; James R Hall; Carol B Moore; Teodoro Bottiglieri; Paul Massman; Ramon Diaz-Arrastia
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-11-20       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.